CLOSTRIDIUM DIFFICILE INFECTIONS
Clinical trials for CLOSTRIDIUM DIFFICILE INFECTIONS explained in plain language.
Never miss a new study
Get alerted when new CLOSTRIDIUM DIFFICILE INFECTIONS trials appear
Sign up with your email to follow new studies for CLOSTRIDIUM DIFFICILE INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a 14-Day pill break the cycle of recurrent c. diff?
Prevention Recruiting nowThis study tests a new treatment called VE303 to see if it can prevent repeat Clostridioides difficile (C. diff) infections. About 852 people who have had C. diff before will take either VE303 or a placebo for 14 days. The main goal is to see if fewer people get another C. diff i…
Matched conditions: CLOSTRIDIUM DIFFICILE INFECTIONS
Phase: PHASE3 • Sponsor: Vedanta Biosciences, Inc. • Aim: Prevention
Last updated May 26, 2026 06:17 UTC
-
C. diff mystery: scientists track Bacteria's escape to stop recurring infections
Knowledge-focused Recruiting nowThis study follows 100 hospitalized adults with Clostridioides difficile infection to track how quickly the bacteria clears from the gut during and after standard antibiotic treatment. Researchers will also examine gut bacteria and immune responses to understand why infections re…
Matched conditions: CLOSTRIDIUM DIFFICILE INFECTIONS
Sponsor: Fondation Hôpital Saint-Joseph • Aim: Knowledge-focused
Last updated May 26, 2026 06:19 UTC